Optimizing Final Pathology Determination in Endometrial Cancer: The Role of PET/CT, MRI, and Biopsy in Serous, Mixed Cell, Clear Cell, and Grade 3 Endometrioid Subtypes.

Diagnostics (Basel) · 2025 · PMC11941150 · PMID 40150074

Europe PMC DOI

hedged sentence

0.3360

closest p · 6.7× alpha

0.3360

boldest claim

The sentences

did not reach statistical significancep = 0.336not close (p > 0.1)

A mean SUVmax of 17.96 ± 10.18 was observed in endometrioid adenocarcinomas, though this did not reach statistical significance ( p = 0.336).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.